NeoGenomics is a premier cancer diagnostic, pharma services, and information services company serving oncologists, pathologists, pharmaceutical companies, and academic centers in their pursuit of providing better futures for people living with cancer.
Our vision brings together uncompromising quality, exceptional service, and innovative solutions. Each member of our team is committed to our mission: Save lives by improving patient CARE through Communication, Accuracy, Reliability, and Efficiency.
We believe that precision oncology is a critical component in controlling cancer progression. With our comprehensive menu ranging from traditional to state-of-the-art testing, our clinical diagnostic services support a personalized testing approach, providing tailored and targeted diagnostics to meet your patient’s needs, no matter where they are in their treatment journey.
Our pharma services and data services work synchronously together with you – our partners – to solve the most pressing challenges that patients and their care teams face every day. Our informatics experts can help identify and stratify the right patient cohorts to inform market opportunity, optimize clinical trial design, and improve drug development by increasing patient access to commercial and investigational agents and trials. We are dedicated to providing you and your teams with precise diagnostic testing, helping you bring new therapies to market, and identifying the unique hallmarks of each patient’s disease to enable precision oncology care.
NeoGenomics meets you where you are through our network of CAP-accredited, CLIA-certified facilities in the U.S., our global laboratories, as well as our network of national, certified mobile phlebotomy providers.
Please click on video
Sr. Territory Business Manager
Cell: (856) 981-5992